Wei-Wu He, Director at CASI Pharmaceuticals, Inc. (CASI), bought 630,654 shares at $1.22 ($838K) on 2017-09-14, disclosed to the SEC on 2017-09-18.
Open-market purchase of $838k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 187,625 | $229K | 27.3% |
| 2 | $1.22 | 187,625 | $229K | 27.3% |
| 3 | $1.49 | 127,702 | $190K | 22.7% |
| 4 | $1.49 | 127,702 | $190K | 22.7% |
| Total | $1.33 avg | 630,654 | $838K | 100% |
| Filing → |
| CASI | BUY | 2021-08-20 | $614K | — | Filing → |
| CASI | BUY | 2021-03-30 | $12.3M | — | Filing → |
| CASI | BUY | 2020-11-24 | $976K | — | Filing → |